ZIOP : Summary for ZIOPHARM Oncology Inc - Yahoo Finance

U.S. Markets closed

ZIOPHARM Oncology, Inc. (ZIOP)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
6.21-0.53 (-7.86%)
At close: 4:00PM EST
People also watch
XONHALOCLDXJUNOKITE
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close6.74
Open6.75
Bid6.15 x 100
Ask6.25 x 300
Day's Range6.17 - 6.88
52 Week Range4.45 - 9.74
Volume2,915,508
Avg. Volume1,664,221
Market Cap810.18M
Beta1.93
PE Ratio (TTM)-4.84
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • ZIOPHARM Oncology, Inc. :ZIOP-US: Earnings Analysis: Q4, 2016 By the Numbers : February 22, 2017
    Capital Cubeyesterday

    ZIOPHARM Oncology, Inc. :ZIOP-US: Earnings Analysis: Q4, 2016 By the Numbers : February 22, 2017

    Categories: Yahoo Finance Get free summary analysis ZIOPHARM Oncology, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of ZIOPHARM Oncology, Inc. – Amgen Inc., Bristol-Myers Squibb Company, Nutraceutical International Corporation and Baxter International Inc. (AMGN-US, BMY-US, NUTR-US and BAX-US) that have also reported for this period. ... Read more (Read more...)

  • Investopedia6 days ago

    Ziopharm 4Q Loss 11 Cents a Share Vs 7c Last Year

    Ziopharm's fourth quarter loss was in line with analyst estimates.

  • Associated Press7 days ago

    Ziopharm reports 4Q loss

    On a per-share basis, the Boston-based company said it had a loss of 11 cents. The results matched Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research ...